Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021

  • Sarah Wulf Hanson
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Cristiana Abbafati
    Department of Juridical and Economic Studies, La Sapienza University, Rome, Italy
  • Joachim G. Aerts
    Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Ziyad Al-Aly
    John T. Milliken Department of Internal Medicine, Washington University in St Louis, St Louis, Missouri
  • Charlie Ashbaugh
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Tala Ballouz
    Epidemiology, Biostatistics, and Prevention Institute, University of Zürich, Zurich, Switzerland
  • Oleg Blyuss
    Wolfson Institute of Population Health, Queen Mary University of London, London, England
  • Polina Bobkova
    Clinical Medicine (Pediatric Profile), I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Gouke Bonsel
    EuroQol Research Foundation, Rotterdam, the Netherlands
  • Svetlana Borzakova
    Pirogov Russian National Research Medical University, Moscow
  • Danilo Buonsenso
    Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy
  • Denis Butnaru
    I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Austin Carter
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Helen Chu
    Department of Medicine, University of Washington, Seattle
  • Cristina De Rose
    Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy
  • Mohamed Mustafa Diab
    Center for Policy Impact in Global Health, Duke University, Durham, North Carolina
  • Emil Ekbom
    Uppsala University Hospital, Uppsala, Sweden
  • Maha El Tantawi
    Pediatric Dentistry and Dental Public Health Department, Alexandria University, Alexandria, Egypt
  • Victor Fomin
    Rector’s Office, I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Robert Frithiof
    Department of Surgical Sciences, Anesthesiology, and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
  • Aysylu Gamirova
    Clinical Medicine (General Medicine Profile), I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Petr V. Glybochko
    Administration Department, I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Juanita A. Haagsma
    Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Shaghayegh Haghjooy Javanmard
    Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Erin B. Hamilton
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Gabrielle Harris
    School of Nursing, Duke University, Durham, North Carolina
  • Majanka H. Heijenbrok-Kal
    Department of Rehabilitation Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Raimund Helbok
    Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
  • Merel E. Hellemons
    Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
  • David Hillus
    Department of Infectious Diseases and Respiratory Medicine, Charité Medical University Berlin, Berlin, Germany
  • Susanne M. Huijts
    Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Michael Hultström
    Department of Surgical Sciences, Anesthesiology, and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
  • Waasila Jassat
    Department of Public Health Surveillance and Response, National Institute for Communicable Diseases, Johannesburg, South Africa
  • Florian Kurth
    Department of Infectious Diseases and Respiratory Medicine, Charité University Medical Center Berlin, Berlin, Germany
  • Ing-Marie Larsson
    Department of Surgical Sciences, Anesthesiology, and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
  • Miklós Lipcsey
    Department of Surgical Sciences, Anesthesiology, and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
  • Chelsea Liu
    Department of Epidemiology, Harvard University, Boston, Massachusetts
  • Callan D. Loflin
    School of Nursing, Duke University, Durham, North Carolina
  • Andrei Malinovschi
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
  • Wenhui Mao
    Center for Policy Impact in Global Health, Duke University, Durham, North Carolina
  • Lyudmila Mazankova
    Russian Medical Academy of Continuous Professional Education, Ministry of Healthcare of the Russian Federation, Moscow
  • Denise McCulloch
    Department of Medicine, University of Washington, Seattle
  • Dominik Menges
    Epidemiology, Biostatistics, and Prevention Institute, University of Zürich, Zurich, Switzerland
  • Noushin Mohammadifard
    Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Daniel Munblit
    Department of Pediatrics and Pediatric Infectious Diseases, I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Nikita A. Nekliudov
    Clinical Medicine (General Medicine Profile), I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Osondu Ogbuoji
    Duke Global Health Institute, Duke University, Durham, North Carolina
  • Ismail M. Osmanov
    Pirogov Russian National Research Medical University, Moscow
  • José L. Peñalvo
    Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
  • Maria Skaalum Petersen
    Department of Occupational Medicine and Public Health, Faroese Hospital System, Torshavn, Faroe Islands
  • Milo A. Puhan
    Epidemiology, Biostatistics, and Prevention Institute, University of Zürich, Zurich, Switzerland
  • Mujibur Rahman
    Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Verena Rass
    Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
  • Nickolas Reinig
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Gerard M. Ribbers
    Department of Rehabilitation Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Antonia Ricchiuto
    Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
  • Sten Rubertsson
    Department of Surgical Sciences, Anesthesiology, and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
  • Elmira Samitova
    Russian Medical Academy of Continuous Professional Education, Ministry of Healthcare of the Russian Federation, Moscow
  • Nizal Sarrafzadegan
    Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  • Anastasia Shikhaleva
    Clinical Medicine (Pediatric Profile), I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Kyle E. Simpson
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Dario Sinatti
    Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy
  • Joan B. Soriano
    Hospital Universitario de La Princesa, Madrid, Spain
  • Ekaterina Spiridonova
    Clinical Medicine (General Medicine Profile), I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Fridolin Steinbeis
    Department of Infectious Diseases and Respiratory Medicine, Charité Medical University Berlin, Berlin, Germany
  • Andrey A. Svistunov
    Administration Department, I. M. Sechenov First Moscow State Medical University, Moscow, Russia
  • Piero Valentini
    Department of Woman and Child Health and Public Health, Agostino Gemelli University Polyclinic IRCCS, Rome, Italy
  • Brittney J. van de Water
    Department of Global Health and Social Medicine, Harvard University, Boston, Massachusetts
  • Rita van den Berg-Emons
    Department of Rehabilitation Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
  • Ewa Wallin
    Department of Surgical Sciences, Anesthesiology, and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
  • Martin Witzenrath
    Department of Infectious Diseases and Respiratory Medicine, Charité University Medical Center Berlin, Berlin, Germany
  • Yifan Wu
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Hanzhang Xu
    Department of Family Medicine and Community Health, Duke University, Durham, North Carolina
  • Thomas Zoller
    Department of Infectious Diseases and Respiratory Medicine, Charité Medical University Berlin, Berlin, Germany
  • Christopher Adolph
    Department of Political Science, University of Washington, Seattle
  • James Albright
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Joanne O. Amlag
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Aleksandr Y. Aravkin
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Bree L. Bang-Jensen
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Catherine Bisignano
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Rachel Castellano
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Emma Castro
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Suman Chakrabarti
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • James K. Collins
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Xiaochen Dai
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Farah Daoud
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Carolyn Dapper
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Amanda Deen
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Bruce B. Duncan
    Postgraduate Program in Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
  • Megan Erickson
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Samuel B. Ewald
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Alize J. Ferrari
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Abraham D. Flaxman
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Nancy Fullman
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Amiran Gamkrelidze
    National Center for Disease Control and Public Health, Tbilisi, Georgia
  • John R. Giles
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Gaorui Guo
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Simon I. Hay
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Jiawei He
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Monika Helak
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Erin N. Hulland
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Maia Kereselidze
    National Center for Disease Control and Public Health, Tbilisi, Georgia
  • Kris J. Krohn
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Alice Lazzar-Atwood
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Akiaja Lindstrom
    School of Public Health, University of Queensland, Brisbane, Australia
  • Rafael Lozano
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Deborah Carvalho Malta
    Department of Maternal and Child Nursing and Public Health, Federal University of Minas Gerais, Belo Horizonte, Brazil
  • Johan Månsson
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Ana M. Mantilla Herrera
    School of Public Health, University of Queensland, Brisbane, Australia
  • Ali H. Mokdad
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Lorenzo Monasta
    Clinical Epidemiology and Public Health Research Unit, Burlo Garofolo Institute for Maternal and Child Health, Trieste, Italy
  • Shuhei Nomura
    Department of Health Policy and Management, Keio University, Tokyo, Japan
  • Maja Pasovic
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • David M. Pigott
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Robert C. Reiner
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Grace Reinke
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Antonio Luiz P. Ribeiro
    Department of Internal Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil
  • Damian Francesco Santomauro
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Aleksei Sholokhov
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Emma Elizabeth Spurlock
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Rebecca Walcott
    Evans School of Public Policy and Governance, University of Washington, Seattle
  • Ally Walker
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Charles Shey Wiysonge
    Cochrane South Africa, South African Medical Research Council, Cape Town
  • Peng Zheng
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Janet Prvu Bettger
    Department of Orthopedic Surgery, Duke University, Durham, North Carolina
  • Christopher J. L. Murray
    Institute for Health Metrics and Evaluation, University of Washington, Seattle
  • Theo Vos
    Institute for Health Metrics and Evaluation, University of Washington, Seattle

Description

<jats:sec id="ab-joi220113-4"><jats:title>Importance</jats:title><jats:p>Some individuals experience persistent symptoms after initial symptomatic SARS-CoV-2 infection (often referred to as Long COVID).</jats:p></jats:sec><jats:sec id="ab-joi220113-5"><jats:title>Objective</jats:title><jats:p>To estimate the proportion of males and females with COVID-19, younger or older than 20 years of age, who had Long COVID symptoms in 2020 and 2021 and their Long COVID symptom duration.</jats:p></jats:sec><jats:sec id="ab-joi220113-6"><jats:title>Design, Setting, and Participants</jats:title><jats:p>Bayesian meta-regression and pooling of 54 studies and 2 medical record databases with data for 1.2 million individuals (from 22 countries) who had symptomatic SARS-CoV-2 infection. Of the 54 studies, 44 were published and 10 were collaborating cohorts (conducted in Austria, the Faroe Islands, Germany, Iran, Italy, the Netherlands, Russia, Sweden, Switzerland, and the US). The participant data were derived from the 44 published studies (10 501 hospitalized individuals and 42 891 nonhospitalized individuals), the 10 collaborating cohort studies (10 526 and 1906), and the 2 US electronic medical record databases (250 928 and 846 046). Data collection spanned March 2020 to January 2022.</jats:p></jats:sec><jats:sec id="ab-joi220113-7"><jats:title>Exposures</jats:title><jats:p>Symptomatic SARS-CoV-2 infection.</jats:p></jats:sec><jats:sec id="ab-joi220113-8"><jats:title>Main Outcomes and Measures</jats:title><jats:p>Proportion of individuals with at least 1 of the 3 self-reported Long COVID symptom clusters (persistent fatigue with bodily pain or mood swings; cognitive problems; or ongoing respiratory problems) 3 months after SARS-CoV-2 infection in 2020 and 2021, estimated separately for hospitalized and nonhospitalized individuals aged 20 years or older by sex and for both sexes of nonhospitalized individuals younger than 20 years of age.</jats:p></jats:sec><jats:sec id="ab-joi220113-9"><jats:title>Results</jats:title><jats:p>A total of 1.2 million individuals who had symptomatic SARS-CoV-2 infection were included (mean age, 4-66 years; males, 26%-88%). In the modeled estimates, 6.2% (95% uncertainty interval [UI], 2.4%-13.3%) of individuals who had symptomatic SARS-CoV-2 infection experienced at least 1 of the 3 Long COVID symptom clusters in 2020 and 2021, including 3.2% (95% UI, 0.6%-10.0%) for persistent fatigue with bodily pain or mood swings, 3.7% (95% UI, 0.9%-9.6%) for ongoing respiratory problems, and 2.2% (95% UI, 0.3%-7.6%) for cognitive problems after adjusting for health status before COVID-19, comprising an estimated 51.0% (95% UI, 16.9%-92.4%), 60.4% (95% UI, 18.9%-89.1%), and 35.4% (95% UI, 9.4%-75.1%), respectively, of Long COVID cases. The Long COVID symptom clusters were more common in women aged 20 years or older (10.6% [95% UI, 4.3%-22.2%]) 3 months after symptomatic SARS-CoV-2 infection than in men aged 20 years or older (5.4% [95% UI, 2.2%-11.7%]). Both sexes younger than 20 years of age were estimated to be affected in 2.8% (95% UI, 0.9%-7.0%) of symptomatic SARS-CoV-2 infections. The estimated mean Long COVID symptom cluster duration was 9.0 months (95% UI, 7.0-12.0 months) among hospitalized individuals and 4.0 months (95% UI, 3.6-4.6 months) among nonhospitalized individuals. Among individuals with Long COVID symptoms 3 months after symptomatic SARS-CoV-2 infection, an estimated 15.1% (95% UI, 10.3%-21.1%) continued to experience symptoms at 12 months.</jats:p></jats:sec><jats:sec id="ab-joi220113-10"><jats:title>Conclusions and Relevance</jats:title><jats:p>This study presents modeled estimates of the proportion of individuals with at least 1 of 3 self-reported Long COVID symptom clusters (persistent fatigue with bodily pain or mood swings; cognitive problems; or ongoing respiratory problems) 3 months after symptomatic SARS-CoV-2 infection.</jats:p></jats:sec>

Journal

  • JAMA

    JAMA 328 (16), 1604-, 2022-10-25

    American Medical Association (AMA)

Citations (1)*help

See more

Report a problem

Back to top